Evidence map›Paper›PMID 34532287›Full record

ArticleFrontiers in oncology2021

Carotenoid-Enriched Fractions From

Damilohun Samuel Metibemu, Oluseyi Adeboye Akinloye, Idowu Olaposi Omotuyi, Jude Ogechukwu Okoye, Mustapha Ayodele Popoola, Adio Jamiu Akamo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Damilohun Samuel MetibemuDepartment of Biochemistry, Adekunle Ajasin University, Akungba-Akoko, Nigeria.
Oluseyi Adeboye AkinloyeDepartment of Biochemistry, Federal University of Agriculture, Abeokuta, Nigeria.
Idowu Olaposi OmotuyiDepartment of Biochemistry, Adekunle Ajasin University, Akungba-Akoko, Nigeria.
Jude Ogechukwu OkoyeDepartment of Medical Laboratory Science, Faculty of Health Sciences and Technology, College of Health Sciences, Nnamdi Azikiwe University, Nnewi, Nigeria.
Mustapha Ayodele PopoolaInstitute for Drug Research and Development, Afe Babalola University, Ado Ekiti, Nigeria.
Adio Jamiu AkamoDepartment of Biochemistry, Federal University of Agriculture, Abeokuta, Nigeria.
Federal University of Agriculture · NGAdekunle Ajasin University · NGAfe Babalola University · NGNnamdi Azikiwe University · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human epidermal growth factor 2 (HER2) is overexpressed in about 20% of breast cancer and is associated with a poor prognosis. We report in this study that carotenoid-enriched fractions from

Indexed as

7,12-dimethylbenz[a]anthracene (DMBA)breast cancercarotenoidshuman epidermal growth factor 2liquid chromatography/mass spectrometry

Identifiers

PMID34532287
PMCPMC8438527
OpenAlexW3196718852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.